Shield Therapeutics PLC (AIM:STX, OTCQX:SHIEF) CEO Greg Madison speaks to Proactive's Thomas Warner after releasing a full year trading update for 2022 that showed significant growth in revenues.
Madison reveals which of the company's achievements he was most proud of during the last calendar year, saying that the specialty pharmaceutical company "ended 2022 in a very very productive state."